633 related articles for article (PubMed ID: 12379884)
1. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
3. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
Hainaut P; Pfeifer GP
Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174
[TBL] [Abstract][Full Text] [Related]
4. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
6. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
Matter B; Wang G; Jones R; Tretyakova N
Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
[TBL] [Abstract][Full Text] [Related]
7. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.
Feng Z; Hu W; Hu Y; Tang MS
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15404-9. PubMed ID: 17030796
[TBL] [Abstract][Full Text] [Related]
8. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
9. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
Denissenko MF; Pao A; Tang M; Pfeifer GP
Science; 1996 Oct; 274(5286):430-2. PubMed ID: 8832894
[TBL] [Abstract][Full Text] [Related]
10. On the origin of p53 G:C --> T:A transversions in lung cancers.
Rodin SN; Rodin AS
Mutat Res; 2002 Oct; 508(1-2):1-19. PubMed ID: 12379456
[TBL] [Abstract][Full Text] [Related]
11. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.
Shen YM; Troxel AB; Vedantam S; Penning TM; Field J
Chem Res Toxicol; 2006 Nov; 19(11):1441-50. PubMed ID: 17112231
[TBL] [Abstract][Full Text] [Related]
12. p53 mutational spectra and the role of methylated CpG sequences.
Pfeifer GP
Mutat Res; 2000 May; 450(1-2):155-66. PubMed ID: 10838140
[TBL] [Abstract][Full Text] [Related]
13. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
[TBL] [Abstract][Full Text] [Related]
14. Base damage, local sequence context and TP53 mutation hotspots: a molecular dynamics study of benzo[a]pyrene induced DNA distortion and mutability.
Menzies GE; Reed SH; Brancale A; Lewis PD
Nucleic Acids Res; 2015 Oct; 43(19):9133-46. PubMed ID: 26400171
[TBL] [Abstract][Full Text] [Related]
15. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach.
Tretyakova N; Matter B; Jones R; Shallop A
Biochemistry; 2002 Jul; 41(30):9535-44. PubMed ID: 12135376
[TBL] [Abstract][Full Text] [Related]
16. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons.
Smith LE; Denissenko MF; Bennett WP; Li H; Amin S; Tang M; Pfeifer GP
J Natl Cancer Inst; 2000 May; 92(10):803-11. PubMed ID: 10814675
[TBL] [Abstract][Full Text] [Related]
17. Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells.
Feng Z; Hu W; Rom WN; Costa M; Tang MS
Carcinogenesis; 2003 Apr; 24(4):771-8. PubMed ID: 12727806
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.
Liu Z; Muehlbauer KR; Schmeiser HH; Hergenhahn M; Belharazem D; Hollstein MC
Cancer Res; 2005 Apr; 65(7):2583-7. PubMed ID: 15805253
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53.
Yu D; Berlin JA; Penning TM; Field J
Chem Res Toxicol; 2002 Jun; 15(6):832-42. PubMed ID: 12067251
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
